Olympus Develops DNA Computer


By Kuriko Miyake, IDG News Service

March 7, 2002 | TOKYO - Olympus Optical Co. Ltd. has developed what the company says is the first commercially practical DNA computer that specializes in gene analysis. The computer was developed in conjunction with Akira Toyama, an assistant professor at Tokyo University.

Unlike a conventional microprocessor, which uses electrical impulses and processes information one step at a time, a DNA computer relies on chemical reactions between fragments of DNA. When combined, coded DNA fragments link together to create strands, each one signifying a possible answer to a problem. Further chemical reactions can be used to separate strands and find the desired answer. Because multiple reactions can take place inside a test tube at the same time, the reaction is the equivalent of massively parallel processing.

The pioneer of DNA computing was Leonard Adleman, who successfully applied the method to solving the Hamilton path problem. This has led some people to suggest that DNA computers may eventually succeed silicon-based microprocessors in applications where large amounts of processing power are needed, such as gene analysis, aiding in research of different species in biology, and the diagnosis of various diseases where many calculations are required at once.

The standard manual approach to gene analysis-arranging DNA fragments and observing the chemical reactions-was very time-consuming, says Olympus spokesman Satoshi Ikuta. When DNA computing is applied to gene analysis, what used to take three days can now be done in six hours. DNA computing also allows scientists to observe chemical reactions that occur simultaneously, lowering research costs, says Ikuta.

Olympus says it is the first company to overcome the challenge of building a DNA computer. “The bottleneck was that engineers were required to have expert knowledge in two specific fields,” says Ikuta - information processing engineering and molecular biology, collectively known as genome informatics. To achieve this, Olympus formed a joint venture with Tokyo University’s Toyama a year ago called NovousGene Inc., specializing in genome informatics.

The new computer is divided into two sections: a molecular calculation component and an electronic calculation component. The former calculates DNA combinations of molecules, implements chemical reactions, searches, and pulls out the right DNA results. The latter executes processing programs and analyzes these results. The company will start gene analysis using the DNA computer on a trial basis for a year, and hopes to offer the service on a commercial basis for researchers in 2003.



White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .